General Information
Revision date
2012-10-05
Product name
GLB ALGIMYCIN 600
Chemical name
None
CAS No.
31512-74-0
1.2.1 Relevant identified uses
None established FORMULA None established
Icons in SDS
Company Information
company name
Advantis Technologies
Section 2
2.3 Other hazards
Mild eye irritant, Mucous membrane irritant
Principle Routes of Exposure
Ingestion Eyes Inhalation Chemical Interactions: No known interactions
Medical Conditions Generally Aggravated by Exposure
None known. Human Threshold Response Data Odor Threshold Not established for product. Irritation Threshold Not established for product. Hazardous Materials Identification System / National Fire Protection Association Classifications
Hazard statements
Health Flammability Physical / Instability PPI / Special hazard. HMIS 1 0 NFPA 1 0 Immediate (Acute) Health Effects Inhalation Toxicity: Not expected to be an inhalation hazard at ambient conditions. Inhalation of mist or vapor may cause irritation to the mucous membranes of the respiratory tract. Not expected to be toxic by inhalation. Skin Toxicity: Not expected to cause irritation. Not expected to be toxic from dermal contact. Eye Toxicity: Contact may cause mild irritation consisting of transient redness, swelling, and mucous membrane discharge to the conjunctiva. No corneal involvement or visual impairment is expected. Ingestion Toxicity: May be harmful if swallowed. Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhoea. Acute Target Organ Toxicity: May cause mild eye irritation. Ingestion may cause mild gastrointestinal discomfort.
Potential chronic health
Carcinogenicity: This product is not known or reported to be carcinogenic by any reference source including IARC, OSHA, NTP or EPA. Reproductive and This chemical has been tested in laboratory animals and no evidence of Developmental Toxicity: teratogenicity or fetotoxicity was seen. Inhalation: There are no known or reported effects from chronic exposure except for effects similar to those experienced from acute exposure. Skin Contact: There are no known or reported effects from chronic exposure. Skin Absorption: No significant adverse effects to health would be expected to occur. Ingestion: There are no known or reported effects from chronic ingestion except for effects similar to those experienced from single exposure. Eye Contact: Contact would be expected to cause minor irritation, consisting of transient redness and swelling. Sensitization: This material is not known or reported to be a skin or respiratory sensitizer. A similar product was found to be a negative skin sensitizer in the Guinea pig Buehler method test. Chronic Target Organ Toxicity: There are no known or reported target organ effects from chronic exposure. Supplemental Health Hazard This information is not available. Information :